Midazolam and psilocybin for wellbeing study
Treatments studied
Part of Mental health clinical trials.
This trial tests how two different drugs, midazolam and psilocybin, affect the brain and wellbeing. It may help if you feel your wellbeing has dropped a bit but you don't have a diagnosed mood or anxiety disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are physically healthy and have no major medical conditions.
- You speak English well enough to give consent and fill out forms.
- You have a mild dip in wellbeing but no current depression or anxiety disorder.
- You can have an MRI scan and a brain stimulation procedure (TMS).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of psilocybin can improve well-being in healthy adults who feel their well-being could be better. You will be closely monitored and given support before, during, and after the session.
This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
Hear when a new Psilocybin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.